Table 1.
Characteristic of study population
| Group without IVH and with IVH I and II stage (N = 211; 79 %) | Group with IVH stage III and IV (N = 56; 21 %) | p | |
|---|---|---|---|
| Gender | 0.853a | ||
| Male | 116 (55 %) | 28 (50 %) | |
| Female | 95 (45 %) | 28 (50 %) | |
| Gestational age (week) | 0.019a | ||
| 23–24 | 24 (11.4 %) | 14 (25 %) | |
| 25–26 | 65 (30.8 %) | 21 (37.5 %) | |
| 27–28 | 54 (25.6 %) | 11 (19.6 %) | |
| 29–30 | 45 (21.3 %) | 9 (16.1 %) | |
| 31 | 23 (10.9 %) | 1 (1.8 %) | |
| Birth weight (gram) | 0.464a | ||
| <750 | 38 (18 %) | 14 (25 %) | |
| 750–1000 | 70 (33.2 %) | 21 (37.5 %) | |
| 1000–1500 | 71 (33.6 %) | 15 (26.8 %) | |
| >1500 | 32 (15.2 %) | 6 (10.7 %) | |
| SGA | 0.747b | ||
| Yes | 7 (3.3 %) | 2 (3.6 %) | |
| No | 204 (96.7 %) | 54 (96.4 %) | |
| AST | 0.014a | ||
| Yes | 167 (79.1 %) | 35 (62.5 %) | |
| No or uncompleted | 44 (20.9 %) | 21 (37.5 %) | |
| Mode of delivery | 0.277a | ||
| Vaginal | 86 (40.8 %) | 28 (50 %) | |
| Cesarean section | 125 (59.2 %) | 28 (50 %) | |
| Third level hospitals | 0.005a | ||
| Inborn | 181 (85.8 %) | 42 (75 %) | |
| Outborn | 30 (14.2 %) | 14 (25 %) | |
| Asphyxia | 0.052a | ||
| Yes | 29 (13.7 %) | 13 (23.2 %) | |
| No | 162 (86.3 %) | 43 (76.8 %) | |
| Intrauterine infection | 0.880a | ||
| Yes | 94 (44.5 %) | 26 (46.4 %) | |
| No | 117 (55.5 %) | 30 (53.6 %) | |
| Hypotension therapy | 0.002a | ||
| Yes | 131 (62.1 %) | 47 (83.9 %) | |
| No | 80 (37.9 %) | 9 (16.1 %) | |
| Acidosis therapy | 0.003a | ||
| Yes | 122 (57.8 %) | 45 (80.4 %) | |
| No | 89 (42.2 %) | 11 (19.6 %) | |
| Blood coagulation disorders and/or thrombocytopenia | 0.807b | ||
| Yes | 4 (1.9 %) | 2 (3.6 %) | |
| No | 207 (98.1 %) | 54 (96.4 %) |
aChi-square test
bChi-square test with Yate’s correction